FFFude Feng

Fude Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Fude Feng has a total of 167 co-authors. Here are the top co-authors by number of shared publications:

  • Shu Wang

    Beijing National Laboratory for Molecular Sciences, Key Laboratory of Organic Solids, Institute of Chemistry, Chinese Academy of Sciences, Beijing, PR China

    24 shared publications
  • Ke Du

    MOE Key Laboratory of High Performance Polymer Materials and Technology, and Department of Polymer Science & Engineering, School of Chemistry & Chemical Engineering, Nanjing University, Nanjing 210023, China

    22 shared publications
  • Jian Sun

    Key Laboratory of High Performance Polymer Material and Technology of Ministry of Education, Department of Polymer Science & Engineering, School of Chemistry & Chemical Engineering, Nanjing University, Nanjing, China

    20 shared publications
  • Xia Wang

    Key Laboratory of High Performance Polymer Materials and Technology of Ministry of Education, Department of Polymer Science & Engineering School of Chemistry Nanjing University Nanjing Jiangsu People's Republic of China

    14 shared publications
  • Xiao Li

    Hunan Provincial Key Laboratory of Environmental Catalysis & Waste Regeneration, College of Materials and Chemical Engineering, Hunan Institute of Engineering, Xiangtan 411104, Hunan, China

    13 shared publications
  • Daoben Zhu

    Beijing National Laboratory for Molecular Sciences, Key Laboratory of Organic Solids, Institute of Chemistry, Chinese Academy of Sciences, Beijing 100190 (P.R. China), Fax: (+86) 10‐6263‐6680

    11 shared publications

Latest Publications

  • One‐Pot Conversion of Acridines Into Phototherapeutic Near‐Infrared Spirocyanines

    by Zhaobin Wang, Tianyang Zhang, Xia Wang, Hao Heng, Yulun Wu, Shuhua Li, Fude Feng

    As near‐infrared (NIR) bio‐imaging and phototherapeutic agents, polymethine cyanines have disadvantages in optical properties due to the fast nonradiative transition. Herein, we reported a small‐sized and spirocycle‐fused trimethine acridinocyanine (SpiroCY) via one‐pot oxidative trimerization using oxygen as the oxidant. Theoretical calculations using the Automated Design of Chemical Reaction (ADCR) program elucidate the formation of the O 2 ‐derived hydroperoxyl radical (HO 2 • ) and demonstrate a radical cascade reaction (RCR) mechanism for spirocyanine synthesis. The spiro‐functionalization effect greatly reshapes the photophysical properties of the parent acridinocyanine by improving brightness and suppressing H‐aggregation due to the three‐dimensional architecture and enhanced rigidity, which allows for mitochondria‐targeted NIR‐I and NIR‐II cell imaging at a very low dose (10−100 nM); and switches the parent acridinocyanine into a potential antitumor drug and Type‐I photosensitizer generating superoxide anion radical (O 2 •− ) and hydroxyl radical ( • OH) under 808 nm light irradiation for efficient photodynamic therapy. This work provides a new insight for dye functionalization, adds mechanistic understandings of the spirocyclic effect, and paves a way for developing spiro dyes as unique NIR‐I and NIR‐II imaging and phototherapeutic agents.


  • One‐Pot Conversion of Acridines Into Phototherapeutic Near‐Infrared Spirocyanines

    by Zhaobin Wang, Tianyang Zhang, Xia Wang, Hao Heng, Yulun Wu, Shuhua Li, Fude Feng

    As near‐infrared (NIR) bio‐imaging and phototherapeutic agents, polymethine cyanines have disadvantages in optical properties due to the fast nonradiative transition. Herein, we reported a small‐sized and spirocycle‐fused trimethine acridinocyanine (SpiroCY) via one‐pot oxidative trimerization using oxygen as the oxidant. Theoretical calculations using the Automated Design of Chemical Reaction (ADCR) program elucidate the formation of the O 2 ‐derived hydroperoxyl radical (HO 2 • ) and demonstrate a radical cascade reaction (RCR) mechanism for spirocyanine synthesis. The spiro‐functionalization effect greatly reshapes the photophysical properties of the parent acridinocyanine by improving brightness and suppressing H‐aggregation due to the three‐dimensional architecture and enhanced rigidity, which allows for mitochondria‐targeted NIR‐I and NIR‐II cell imaging at a very low dose (10−100 nM); and switches the parent acridinocyanine into a potential antitumor drug and Type‐I photosensitizer generating superoxide anion radical (O 2 •− ) and hydroxyl radical ( • OH) under 808 nm light irradiation for efficient photodynamic therapy. This work provides a new insight for dye functionalization, adds mechanistic understandings of the spirocyclic effect, and paves a way for developing spiro dyes as unique NIR‐I and NIR‐II imaging and phototherapeutic agents.


  • In-Cell Photoactivated Porphyrin Demetalation for Reductive Photodynamic Therapy under Hypoxia

    by Xia Wang, Zhaobin Wang, Mudi Li, Fude Feng

    Photocontrolled metal ion release systems for hypoxic tumor therapy are rare. Metalloporphyrins can realize photoactivated hydride (H-) therapy under hypoxia, but studies combining H- therapy with metal ion release have not been reported. Herein, we reported that zinc-coordinated porphyrin (ZnPor) can undergo photochemical Zn2+ release, accompanied by photoconversion of ZnPor into phlorin (Phl) as a H- donor, providing a pathway for the conversion between metalloporphyrins and porphyrins based on the instability of phlorins. Further, morpholine-modified metalloporphyrin (lysoZnPor) is photoactivatable in situ to undergo demetalation for lysosome-targeted H- therapy. Driven by light and endogenous 1,4-dihydronicotinamide adenine dinucleotide (NADH), lysoZnPor releases Zn2+ and generates lysoPhl. The photoredox cycle between phlorin and porphyrin harnesses NADH as a hydride donor, and ubiquinone as an electron acceptor induces lysosomal dysfunction and consequently cell death, achieving photoactivated H- therapy on hypoxic tumor cells. This study highlights the potential of photocontrolled porphyrin demetalation and reductive photodynamic therapy.

  • One-pot synthesis of a quaternary ammonium-functionalized methylene blue-backboned polymer for robust NADH oxidation

    by Xuetong Cai, Chi Meng, Yajie Zhang, Fude Feng

    A one-pot synthesized quaternary ammonium-functionalized methylene blue-backboned polymer effectively catalyzes the oxidation of NADH as a highly stable artificial enzyme mimic.

  • Converting spiropyran derivatives into trimethine cyanine dyes

    by Luyang Ji, He Hang, Jiaqi Wang, Xia Wang, Fude Feng

  • Open Access

    Activatable self-reporting cyclization reaction for in-cell synthesis of cyclocyanines

    by He Hang, Xia Wang, Zhaobin Wang, Chi Meng, Qihang Sun, Ziyue Yang, Fude Feng

    A formaldehyde-participating click-like cyclization method for one-pot synthesis of cyclic cyanines was established using dimeric Fischer bases. The in-cell cyanine synthesis was activated by hemin in the mitochondria of cancer cells.


  • A new perspective on intracellular redox environment-mediated innovative photodynamic therapy

    by Xia Wang, Chi Meng, Jinlei Peng, Fude Feng

    This review overviews innovative strategies in redox environment-mediated photodynamic therapy (PDT), particularly highlighting contributions to the new concept of reductive PDT that involves reactive hydrogen species (RHS) fighting tumour hypoxia.


  • Hydrogen radical-based prodrug photoactivation by modulating bond dissociation energy of a phenolic photosensitizer

    by Jian Sun, Jinlei Peng, Junwei Zhou, Xiaoran Zhang, Chuanwei Zhu, Rong Wang, Fude Feng, Shu Wang


  • Auto‐Deactivation of BODIPY‐Derived Type I Photosensitizer Post Photodynamic Therapy under Hypoxia

    by Xia Wang, Zhaobin Wang, He Hang, Fude Feng

    The long‐lasting activity of photosensitizers during photodynamic therapy (PDT) causes excessive damage and arouses great concerns about biosafety. Herein, we synthesized a pyridinium‐decorated diiodo‐BODIPY compound (PyBDP) and investigated its photosensitizing activity under hypoxic condition in the presence of NADH that is abundant in the mitochondria of hypoxic tumors. The unique property of PyBDP lies in the redox environment‐dependent photo‐response. At green light exposure, PyBDP is converted into a colorless inactive form by interacting with NADH in a two‐step one‐electron transfer process. Interestingly, the NADH‐dependent hydrogenation of PyBDP is affected by the presence of cytochrome c (Cyt cox) that is an important component of mitochondrial electron transport chain (Mito‐ETC), unless Cyt cox is exhausted. Active radical species is produced during the photocatalytic reaction, which adds the understanding of PyBDP‐induced photodamage. Therefore, we applied the strategy of auto‐deactivation PDT using a BODIPY photosensitizer by tethering triphenylphosphonium to PyBDP. After PDT effect in a type I pathway, the photosensitizer underwent almost entire auto‐deactivation in hypoxic HeLa cells. This work paves a way for the development of reductive PDT with enhanced safety and efficacy in fighting hypoxic tumors independent on reactive oxygen species (ROS).


  • Open Access

    Photoactivated hydride therapy under hypoxia beyond ROS

    by Xia Wang, Yijian Gao, Ting Wang, Zhaobin Wang, He Hang, Shengliang Li, Fude Feng

    As compared to oxidative phototherapy, studies on reactive reductive species-participating photodynamic therapy (PDT) are rare. Porphyrins are typical photosensitizers restricted with oxygen level, but efficacy and selectivity are always uncompatible in PDT. Herein, we reported that phlorins are ideal hydride (H–) donors and explored water-soluble triphenylphosphonium-modified zinc-coordinated porphyrin (mitoZnPor) for in situ photogeneration of zinc-cored phlorin (mitoZnPhl). Driven by 1,4-dihydronicotinamide adenine dinucleotide (NADH), the mitoZnPor/mitoZnPhl couple can reduce electron acceptors like iron heme and ubiquinone that play key roles in mitochondrial electron transportation chain (Mito-ETC). Under hypoxia, mitoZnPor showed excellent cancer-selectivity and highly efficient in vitro PDT effect with IC50 at nanomolar levels and potent tumor growth inhibition in a 4T1 tumor-xenografted mouse model with good biosafety, which underlines great potentials of Mito-ETC targeted non-classical PDT via a H–-transfer mechanism beyond reactive oxygen species (ROS) in precision cancer phototherapy using NADH as a biomarker and original electron donor.